|
Death
|
0.078
|
0
|
3
|
3,831
|
Duration here is expected mean survival without the event, as estimated as weighted average from Zegers et al. [29]
|
Vincristine administered by intrathecal route.
|
|
Permanent disability
|
0.047
|
To be determined
|
6
|
6,649
|
Costs exclude long-term care. No data on mean duration, but a given adverse event is more likely to be fatal in an older person, so mean survival assumed to be a little longer than life years lost in those who died.
|
Haemorrhagic stroke in patient prescribed warfarin and macrolide antibiotics.
|
|
Moderate disability
|
0.617
|
To be determined
|
0.2
|
5,973
|
Duration ≤6 months in 70% of cases (Baker et al. [30])
|
Pulmonary embolism in large patient given standard (inadequate) dose of heparin.
|
|
Minimal effect
|
0.257
|
To be determined
|
0.05
|
2,979
| |
Transient urticarial rash in known allergic patient given penicillin.
|
